Showing results (21-30 of 397) with videos related to
Sort By:
Pageof 40
Progress in Neurobiology|February 20, 2008
Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALSBradley J Turner, Kevin TalbotTrends in Genetics : TIG|April 19, 2011
Genetic therapies for RNA mis-splicing diseasesSuzan M Hammond, Matthew J A WoodExpert Reviews in Molecular Medicine|February 2, 2012
RNA therapy for polyglutamine neurodegenerative diseasesLauren M Watson, Matthew J A WoodJournal of Molecular Medicine (Berlin, Germany)|July 14, 2011
The miRNA pathway in neurological and skeletal muscle disease: implications for pathogenesis and therapyChristopher R Sibley, Matthew J A WoodCurrent Pharmaceutical Design|November 13, 2012
Cell penetrating peptide delivery of splice directing oligonucleotides as a treatment for Duchenne muscular dystrophyCorinne A Betts, Matthew J A WoodPlos One|October 28, 2011
Identification of allele-specific RNAi effectors targeting genetic forms of Parkinson's diseaseChristopher R Sibley, Matthew J A WoodHuman Molecular Genetics|March 20, 2009
Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeuticsMarc S Weinberg, Matthew J A WoodEssays in Biochemistry|July 9, 2013
Therapeutic targeting of non-coding RNAsThomas C Roberts, Matthew J A WoodMed (New York, N.Y.)|November 12, 2022
RNase-H-mediated silencing in the CNS proves predictably nontrivialMichael P Moazami, Matthew J A WoodActa Neuropathologica Communications|September 8, 2016
Pathogenesis of FUS-associated ALS and FTD: insights from rodent modelsMatthew Nolan, Kevin Talbot, Olaf AnsorgePageof 40